The Wegovy pill is an oral form of semaglutide designed for patients who prefer not to use injections
Diet and exercise are certainly valuable weight loss strategies, but they result in all-over weight loss, not targeted loss of fat deposits
That is preclinical, in a disease model
The potential for significant revenue from compounded semaglutide could create conflicts of interest, leading providers to overlook the risks involved in compounding
Whether you choose the injection or the oral tablet, semaglutide has the potential to be a valuable tool in your weight management journey, helping you achieve your goals and enhance your overall well-being
To promote weight loss, semaglutide delays gastric emptying, increases satiety, decreases appetite and energy intake